Peapack-Gladstone Financial Corp’s Zimmer Biomet ZBH Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,488	Closed	-$245K	–	699
2025 Q3	$245K	Hold	2,488	–	–	﹤0.01%	621
2025 Q2	$227K	Sell	2,488 -354	-12%	-$34.2K	﹤0.01%	609
2025 Q1	$322K	Buy	2,842 +248	+10%	+$26.5K	﹤0.01%	548
2024 Q4	$274K	Buy	2,594 +19	+0.7%	+$2.04K	﹤0.01%	586
2024 Q3	$278K	Sell	2,575 -94	-4%	-$10.3K	﹤0.01%	592
2024 Q2	$290K	Sell	2,669 -2,379	-47%	-$280K	﹤0.01%	565
2024 Q1	$666K	Hold	5,048	–	–	0.01%	443
2023 Q4	$614K	Sell	5,048 -4	-0.1%	-$446	0.01%	448
2023 Q3	$567K	Buy	5,052 +14	+0.3%	+$1.78K	0.01%	453
2023 Q2	$734K	Hold	5,038	–	–	0.01%	427
2023 Q1	$651K	Buy	5,038 +32	+0.6%	+$4.02K	0.01%	433
2022 Q4	$638K	Sell	5,006 -250	-5%	-$29K	0.01%	433
2022 Q3	$550K	Sell	5,256 -70	-1%	-$7.68K	0.01%	446
2022 Q2	$560K	Hold	5,326	–	–	0.01%	428
2022 Q1	$681K	Sell	5,326 -1,092	-17%	-$132K	0.01%	421
2021 Q4	$792K	Buy	6,418 +743	+13%	+$97.2K	0.02%	415
2021 Q3	$806K	Sell	5,675 -1,191	-17%	-$175K	0.02%	399
2021 Q2	$1.07M	Hold	6,866	–	–	0.03%	331
2021 Q1	$1.07M	Buy	6,866 +536	+8%	+$83K	0.03%	311
2020 Q4	$947K	Sell	6,330 -190	-3%	-$26.8K	0.03%	263
2020 Q3	$862K	Buy	6,520 +159	+2%	+$20.8K	0.03%	237
2020 Q2	$737K	Sell	6,361 -79	-1%	-$9.1K	0.03%	245
2020 Q1	$632K	Sell	6,440 -47	-0.7%	-$6.16K	0.03%	250
2019 Q4	$942K	Sell	6,487 -963	-13%	-$133K	0.04%	203
2019 Q3	$992K	Buy	7,450 +394	+6%	+$50.9K	0.04%	197
2019 Q2	$806K	Sell	7,056 -127	-2%	-$14.9K	0.03%	220
2019 Q1	$890K	Sell	7,183 -201	-3%	-$22.8K	0.04%	197
2018 Q4	$743K	Buy	7,384 +14	+0.2%	+$1.57K	0.04%	199
2018 Q3	$941K	Buy	7,370 +1,896	+35%	+$225K	0.05%	191
2018 Q2	$592K	Buy	5,474 +103	+2%	+$11.2K	0.03%	218
2018 Q1	$569K	Hold	5,371	–	–	0.03%	220
2017 Q4	$629K	Buy	5,371 +92	+2%	+$10.4K	0.03%	212
2017 Q3	$600K	Hold	5,279	–	–	0.03%	209
2017 Q2	$658K	Buy	5,279 +228	+5%	+$27K	0.04%	202
2017 Q1	$599K	Hold	5,051	–	–	0.04%	205
2016 Q4	$506K	Buy	5,051 +2,450	+94%	+$263K	0.03%	205
2016 Q3	$328K	Buy	2,601 +120	+5%	+$14.8K	0.02%	257
2016 Q2	$290K	Hold	2,481	–	–	0.02%	271
2016 Q1	$257K	Sell	2,481 -92	-4%	-$8.9K	0.02%	282
2015 Q4	$256K	Hold	2,573	–	–	0.02%	293
2015 Q3	$235K	Hold	2,573	–	–	0.02%	297
2015 Q2	$273K	Buy	+2,573	New	+$285K	0.02%	280
2014 Q2	–	Sell	-2,433	Closed	-$223K	–	298
2014 Q1	$223K	Hold	2,433	–	–	0.02%	280
2013 Q4	$220K	Sell	2,433 -226	-8%	-$19.6K	0.02%	272
2013 Q3	$212K	Sell	2,659 -279	-9%	-$22K	0.02%	271
2013 Q2	$214K	Buy	+2,938	New	+$220K	0.02%	271

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Peapack-Gladstone Financial Corp's ZBH Position: Q4 2025 in Review

Peapack-Gladstone Financial Corp sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,488 shares — an estimated $245K sold.

Peapack-Gladstone Financial Corp first reported a position in ZBH in Q2 2013 and held it in 46 quarters. The position peaked at $1.07M in Q2 2021. 949 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Peapack-Gladstone Financial Corp reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
Peapack-Gladstone Financial Corp sold 2,488 Zimmer Biomet shares in Q4 2025, an estimated $245K.
Peapack-Gladstone Financial Corp first reported a position in Zimmer Biomet in Q2 2013 and held it in 46 quarters.
Peapack-Gladstone Financial Corp's Zimmer Biomet position peaked at $1.07M in Q2 2021.
949 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q4 2025, filed 10 Feb 2026.